ComASP^® Cefiderocol 0.008-128 is a quantitative broth microdilution method intended for the in vitro determination of antimicrobial susceptibility of bacteria.

ComASP Cefiderocol consists of polystyrene microtiter panels containing lyophilized concentrations of cefiderocol and tubes of media (iron-depleted, cation-adjusted Mueller Hinton broth), which are used to determine the minimum inhibitory concentration (MIC) in μg/mL using overnight incubation and manual reading procedures. ComASP Cefiderocol at concentrations of 0.008-128 μg/mL should be interpreted at 16-20 hours of incubation.

ComASP Cefiderocol can be used to determine the MIC of cefiderocol against the following microorganisms for which cefiderocol has been shown to be active clinically and in-vitro according to the FDA-drug approved label:

• Acinetobacter baumannii complex
• Escherichia coli
• Enterobacter cloacae complex
• Klebsiella pneumoniae
• Proteus mirabilis
• Pseudomonas aeruginosa
• Serratia marcescens

Download the US-FDA cleared ComASP^® Cefiderocol 0.008-128 technical sheet here.

Find out more about our solutions for tackling AMR or use the Request Information button to email us directly.